Home LiteratureArticle Details
PMID: 26033820 Published · ppublish English Letter Comment

Negative Trials for Foreseeable Safety Reasons in Advanced Hepatocellular Carcinoma: How Long Are We Going to Take Lightly Pharmacokinetics of Tyrosine Kinase Inhibitors?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·Vol. 33 ·No. 22 ·2015-08-01 ·Pages 2484-5

Bouattour M, Rousseau B, Wassermann J, Payancé A, Huillard O

Abstract

暂无摘要

MeSH Terms
Antineoplastic Agents/therapeutic use Carcinoma, Hepatocellular/drug therapy Female Humans Indazoles/therapeutic use Liver Neoplasms/drug therapy Male Niacinamide/analogs & derivatives Phenylurea Compounds/therapeutic use Protein Kinase Inhibitors/therapeutic use
Chemicals
Antineoplastic Agents Indazoles Phenylurea Compounds Protein Kinase Inhibitors Niacinamide
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bouattour Mohamed
Beaujon University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris VII Diderot, Clichy, France mohamed.bouattour@bjn.aphp.fr.
Rousseau Benoît
Henri Mondor University Hospital, Assistance Publique Hôpitaux de Paris, Paris Est Créteil Université, INSERM U 955 Team 18, Paris, France.
Wassermann Johanna
Pitié-Salpêtrière University Hospital, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie Paris VI, Paris, France.
Payancé Audrey
Beaujon University Hospital, Assistance Publique Hôpitaux de Paris, Université Paris VII Diderot, Clichy, France.
Huillard Olivier
Angiogenesis Inhibitors Multidisciplinary Study Group, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris, France.
Article Info
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Abbr.
J Clin Oncol
ISSN
1527-7755
DOI
10.1200/JCO.2014.60.6954
Email
mohamed.bouattour@bjn.aphp.fr
Published
2015-08-01
Epub
2015-00-01
Pages
2484-5
Language
English
Region
United States
NLM ID
8309333
Subset
IM
Corrections
CommentOn
PMID: 25488963
CommentIn
PMID: 26033815
External Links
PubMed source DOI: 10.1200/JCO.2014.60.6954 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2